NCT00762554 is a NA clinical trial of Depodur in Analgesia, sponsored by Goodman, Evan, M.D..

Who is sponsoring NCT00762554?

NCT00762554 is sponsored by Goodman, Evan, M.D..

What drugs are being tested in NCT00762554?

Interventions in NCT00762554: Depodur, Depodur, Fentanyl.

Is NCT00762554 still recruiting?

NCT00762554 is currently withdrawn. Last updated 14 March 2022.

Last reviewed 2022-03-14 · How we verify

NCT00762554

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Comparison of Single Dose Depodur With Fentanyl Infusion for Post-Cesarean Section Analgesia

Withdrawn NA Last updated 14 March 2022

What this trial tests

NA trial testing Depodur in Analgesia. Withdrawn.

Timeline

1 October 2008

Primary endpoint
1 June 2009

1 June 2009

Quick facts

Lead sponsor	Goodman, Evan, M.D.
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Start date	1 October 2008
Primary completion	1 June 2009
Estimated completion	1 June 2009
Sites	1 location across United States

Drugs / interventions tested

Depodur — full drug profile →
Depodur — full drug profile →
Fentanyl (fentanyl) — full drug profile →

Conditions studied

Analgesia — all drugs for Analgesia →

Sponsor

Goodman, Evan, M.D. — full company profile →

Who can join

Adults 18 to 45, female only, with Analgesia. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Degree of analgesia (measured on a 10-point scale)
Time frame: 48 hours post-operatively

Sponsor's own description

Epidurally administered Depodur provides equal or superior analgesia as an epidural infusion of fentanyl for the first 48 hours after a cesarean section.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Analgesia

Currently open trials in the same condition.

NCT07249827 — A Randomized Comparison Between 0.67 mcg/kg, 1 mcg/kg, and 1.33 mcg/kg of Perineural Dexmedetomidine for Ultrasound-Guid · Phase 2 · recruiting
NCT07250230 — Effect of Perioperative High-dose Transdermal Nicotine Patch on Pain Sensitivity Among Male Abstinent Tobacco Smokers Un · NA · recruiting
NCT07337629 — Single Dose Preemptive Paracetamol or Ibuprofen Before Septrorhinoplasty on Intra- and Postoperative Opioid Consumption. · recruiting
NCT07310953 — Clinical Utility of the Numerical Verbal Scale (NVS) and the Pain and Functional Activity Scale (PFAS) in the Management · NA · recruiting
NCT06869967 — Evaluation of Postoperative Pain Control in Ear Surgery · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00762554 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Goodman, Evan, M.D.
Last refreshed: 14 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00762554.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing